Your profile :General public|Researcher|Student|Companies / Communities
 
Labex Toucan
Investissements d'avenir
Research   ›   Patents Print this page
 

Patents

Document(s) 1 to 2 out of 2
Title
 
CHK1 and POLQ gene expression predicts AML patient survival (2014)
Author(s): JS Hoffmann, C Cazaux, A Fernandez-Vidal, C Récher

INSERM-Transfert Patent

Adenosine-based cyclic dinucleotides as antagonists of the G protein coupled adenosine receptor [réf. EP1330650.1] (2001)
Author(s): Tosolini M., Fournié JJ.

INSERM patent

Document(s) 1 to 2 out of 2
Mobile site Laboratoire d’Excellence Toulouse CancerLaboratoire d’Excellence Toulouse Cancer
Calendar

ILSG - 23rd annual meeting
2014, 2nd-4th of June
Tools
ContactContact
MapMap
DirectoryDirectory
GlossaryGlossary
PartnersPartners
               
Inserm CNRS Université Toulouse 3 - Paul Sabatier Université Joseph Fourier - Grenoble Agence Nationale de la Recherche Fondation RITC